Management of small cell lung cancer

被引:21
作者
Johnson, BE
机构
[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1016/S0272-5231(03)00070-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Small-cell lung carcinoma typically presents as a central endobronchial lesion in chronic cigarette smokers with hilar enlargement and disseminated disease. The diagnostic pathology should be reviewed by a pathologist accomplished in reading pulmonary pathology. If any doubts exist in the diagnosis, additional special stains or diagnostic materials should be obtained. The introduction of combination chemotherapy as treatment for this disease has resulted in high response rates and prolonged survival. The management of small-cell lung cancer largely is based on systemic treatment with combination chemotherapy rather than surgical resection, which typically is used for non-small-cell lung cancers.
引用
收藏
页码:225 / +
页数:16
相关论文
共 163 条
[71]   Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide cisplatin followed by cyclophosphamide, doxorubicin, and vincristine [J].
Johnson, BE ;
Bridges, JD ;
Sobczeck, M ;
Gray, J ;
Linnoila, RI ;
Gazdar, AF ;
Hankins, L ;
Steinberg, SM ;
Edison, M ;
Frame, JN ;
Pass, H ;
Nesbitt, J ;
Holden, D ;
Mulshine, JL ;
Glatstein, E ;
Ihde, DC .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :806-813
[72]  
Johnson BE, 1997, CANCER, V79, P35
[73]   NEUROLOGIC, COMPUTED CRANIAL TOMOGRAPHIC, AND MAGNETIC-RESONANCE IMAGING ABNORMALITIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - FURTHER FOLLOW-UP OF 6-YEAR TO 13-YEAR SURVIVORS [J].
JOHNSON, BE ;
PATRONAS, N ;
HAYES, W ;
GRAYSON, J ;
BECKER, B ;
GNEPP, D ;
ROWLAND, J ;
ANDERSON, A ;
GLATSTEIN, E ;
IHDE, DC ;
FRANK, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) :48-56
[74]   PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL [J].
JOHNSON, DH ;
GRECO, FA ;
STRUPP, J ;
HANDE, KR ;
HAINSWORTH, JD .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1613-1617
[75]   Value and accuracy of cytology in addition to histology in the diagnosis of lung cancer at flexible bronchoscopy [J].
Jones, AM ;
Hanson, IM ;
Armstrong, GR ;
O'Driscoll, BR .
RESPIRATORY MEDICINE, 2001, 95 (05) :374-378
[76]   Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): A combined multivariable analysis on data from nine centres [J].
Jorgensen, LGM ;
Osterlind, K ;
Genolla, J ;
Gomm, SA ;
Hernandez, JR ;
Johnson, PWM ;
Lober, J ;
Splinter, TAW ;
Szturmowicz, M .
BRITISH JOURNAL OF CANCER, 1996, 74 (03) :463-467
[77]   ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH THE SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION AND WITH DIABETES-INSIPIDUS [J].
KAMOI, K ;
EBE, T ;
KOBAYASHI, O ;
ISHIDA, M ;
SATO, F ;
ARAI, O ;
TAMURA, T ;
TAKAGI, A ;
YAMADA, A ;
ISHIBASHI, M ;
YAMAJI, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (05) :1385-1390
[78]  
KARRER K, 1989, J THORAC CARDIOV SUR, V97, P168
[79]   Prognostic factors and prognostic staging system for small cell lung cancer [J].
Kawahara, M ;
Fukuoka, M ;
Saijo, N ;
Nishiwaki, Y ;
Ikegami, H ;
Tamura, T ;
Shimoyama, M ;
Suemasu, K ;
Furuse, K .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) :158-165
[80]   Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor [J].
Keime-Guibert, F ;
Graus, F ;
Broët, P ;
Reñé, R ;
Molinuevo, JL ;
Ascaso, C ;
Delattre, JY .
NEUROLOGY, 1999, 53 (08) :1719-1723